Emerging threats in antifungal-resistant fungal pathogens
The use of antifungal drugs in the therapy of fungal diseases can lead to the development of antifungal resistance. Resistance has been described for virtually all antifungal agents in diverse pathogens including Candida and Aspergilli species. The majority of resistance mechanisms have also been el...
Main Author: | Dominique eSanglard |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2016-03-01
|
Series: | Frontiers in Medicine |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fmed.2016.00011/full |
Similar Items
-
Antifungal Resistance: Specific Focus on Multidrug Resistance in <i>Candida auris</i> and Secondary Azole Resistance in <i>Aspergillus fumigatus</i>
by: Sevtap Arikan-Akdagli, et al.
Published: (2018-12-01) -
Comparative Genomics for the Elucidation of Multidrug Resistance in Candida lusitaniae
by: Abhilash Kannan, et al.
Published: (2019-12-01) -
Antifungal Drug Repurposing
by: Jong H. Kim, et al.
Published: (2020-11-01) -
Evolutionary Emergence of Drug Resistance in Candida Opportunistic Pathogens
by: Ewa Ksiezopolska, et al.
Published: (2018-09-01) -
Indifferent effect of nonsteroidal anti-inflammatory drugs (NSAIDs) combined with fluconazole against multidrug-resistant Candida auris
by: Fatemeh Ahangarkani, et al.
Published: (2019-09-01)